Low Dose Naltrexone
Although Naltrexone was originally marketed and used for another purpose, the use of a much smaller dose has shown promise in fibromyalgia, Lyme's disease, chronic pain, inflammatory conditions, allergies and thyroid disease. With few side-effects and contra-indications, LDN can improve function for many. LDN has been in use in North America since 1985 for autoimmune diseases however has more recently been adopted for additional uses. The medication is in the category of opiate antagonist which is used to treat narcotic addiction and overdose however for the use of immune mobilization is used in much smaller doses (1/10-1/100th of the dose).
In layman terms, no-one is really sure how LDN works – there are multiple possible pathways being investigated. Due to the number of biological systems affected by inhibition of receptors that LDN binds to, this is not surprising and research is ongoing in many areas. The most exciting being its apparent ability to block many auto-immune diseases, and even more excitingly being able to stop the growth or spread of some tumor types in animals.
For more info please download Low-dose Naltrexone (LDN) Fact Sheet PDF provided by LDN Research Trust
Available by telemedicine across the country.